Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Treating beyond symptoms with a view to improving patient outcomes in inflammatory bowel diseases
Background and aims Treatment goals in inflammatory bowel diseases are evolving beyond
the control of symptoms towards the tight control of objectively-measured gastrointestinal …
the control of symptoms towards the tight control of objectively-measured gastrointestinal …
Optimising monitoring in the management of Crohn's disease: a physician's perspective
P Papay, A Ignjatovic, K Karmiris… - Journal of Crohn's …, 2013 - academic.oup.com
Management of Crohn's disease has traditionally placed high value on subjective symptom
assessment; however, it is increasingly appreciated that patient symptoms and objective …
assessment; however, it is increasingly appreciated that patient symptoms and objective …
Adalimumab induces and maintains mucosal healing in patients with Crohn's disease: data from the EXTEND trial
BACKGROUND & AIMS: We investigated the efficacy of adalimumab for inducing and
maintaining mucosal healing in patients with Crohn's disease (CD). METHODS: A …
maintaining mucosal healing in patients with Crohn's disease (CD). METHODS: A …
Implementing changes in clinical practice to improve the management of Crohn's disease
R Panaccione, T Hibi, L Peyrin-Biroulet… - Journal of Crohn's and …, 2012 - Elsevier
The introduction of anti-tumour necrosis factor therapies has provided highly effective
treatments for Crohn's disease, making it possible to significantly improve the prognosis of …
treatments for Crohn's disease, making it possible to significantly improve the prognosis of …
Clinical, biological, and endoscopic responses to adalimumab in antitumor necrosis factor-naive Crohn's disease: predictors of efficacy in clinical practice
Materials and methods A prospective analysis was carried out of 68 antitumor necrosis
factor-naive Crohn's disease patients treated with adalimumab for 2 years. Clinical and …
factor-naive Crohn's disease patients treated with adalimumab for 2 years. Clinical and …
Evaluation of “top-down” treatment of early Crohn's disease by double balloon enteroscopy
R Fan, J Zhong, ZT Wang, SY Li… - World Journal of …, 2014 - pmc.ncbi.nlm.nih.gov
AIM: To assess “top-down” treatment for deep remission of early moderate to severe Crohn's
disease (CD) by double balloon enteroscopy. METHODS: Patients with early active …
disease (CD) by double balloon enteroscopy. METHODS: Patients with early active …
The future of inflammatory bowel disease management: combining progress in trial design with advances in targeted therapy
S Travis, BG Feagan, P Rutgeerts… - Journal of Crohn's …, 2012 - academic.oup.com
Anti-tumour necrosis factor antagonists have appreciably improved patient outcomes in
Crohn's disease, shifting the goals of treatment from control of symptoms to clinical …
Crohn's disease, shifting the goals of treatment from control of symptoms to clinical …
AbbVie en gastroenterología
O Seco, EM Continua - abbviepro.com
Nuestro compromiso y apuesta por la gastroenterología se refleja en nuestros más de 10
años de experiencia en esta área. Continuamos trabajando e investigando para encontrar …
años de experiencia en esta área. Continuamos trabajando e investigando para encontrar …
Adalimumab in der Behandlung des adulten Morbus Crohn–Update eines Konsensus der Arbeitsgruppe Chronisch Entzündliche Darmerkrankungen der …
G Novacek, T Haas, P Knoflach… - Zeitschrift für …, 2013 - thieme-connect.com
TNF-alpha-Antikörper haben den Verlauf von Morbus Crohn mit moderatem bis schwerem
Verlauf wesentlich verbessert. Adalimumab ist der erste vollständig humane, monoklonale …
Verlauf wesentlich verbessert. Adalimumab ist der erste vollständig humane, monoklonale …
[PDF][PDF] Ocena wpływu leczenia przeciwciałami anty-TNF-alfa na ekspresję wybranych receptorów oraz białek biorących udział w procesie apoptozy nabłonka i …
LP Eder - wbc.poznan.pl
Jeszcze do połowy XX wieku uważano, że jedynym procesem prowadzącym do śmierci
komórek jest martwica (nekroza). W latach 60-tych zaczęto jednak opisywać zjawisko, które …
komórek jest martwica (nekroza). W latach 60-tych zaczęto jednak opisywać zjawisko, które …